Hand-out
Press Releases
Apnimed to Participate in the 24th Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., March 26, 2025 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular dysfunction associated with obstructive sleep apnea
